Consistently, immunofluorescence assay also confirmed the significantly suppressed CARM1 level in ADM-treated tumor cells (Figure 4F), and SA-β-gal assay also indicated that ADM-induced cell senescence could be notably reversed by the overexpression of CRRM1 (Figure 4G). The gene discussed is CARM1; the disease is neoplasm.